Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa
Abstract Background Multi-drug resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in pregnant women is a cause for concern globally; few data have described the safety of second-line anti-TB medications during pregnancy. We aim to describe TB treatment and pregnancy outcomes among pregnant...
Saved in:
Main Authors: | Idah Mokhele (Author), Nelly Jinga (Author), Rebecca Berhanu (Author), Thandi Dlamini (Author), Lawrence Long (Author), Denise Evans (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa
by: Lise Jamieson, et al.
Published: (2019) -
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
by: Denise Evans, et al.
Published: (2018) -
Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
by: Kaitlyn M. Berry, et al.
Published: (2019) -
Perspectives of pregnant women on maternal health information handouts at KwaZulu-Natal sub-district
by: Thandi M. Dlamini, et al.
Published: (2024) -
Tuberculosis prevention in HIV-infected pregnant women in South Africa
by: C E Martin, et al.
Published: (2012)